clarithromycin has been researched along with eye in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CL; Chen, CY; Chen, PL; Hsu, SM; Huang, FC; Hung, JH; Jou-Chen Huang, E; Ko, WC; Lai, CC; Lai, CH; Lin, SH; Teng, YT; Tseng, SH; Wang, SH; Wu, CL | 1 |
| Alshehri, S; Bin-Jumah, M; Gilani, SJ; Imam, SS; Jahangir, MA; Kala, C; Taleuzzaman, M; Yasir, M; Zafar, A | 1 |
2 other study(ies) available for clarithromycin and eye
| Article | Year |
|---|---|
Postoperative Mycobacteroides abscessus subsp. abscessus endophthalmitis: Clinical analysis of 12 clustered adults and a proposed therapeutic algorithm.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Amikacin; Anti-Bacterial Agents; Clarithromycin; Endophthalmitis; Eye; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Postoperative Complications; Taiwan; Vitrectomy; Young Adult | 2020 |
Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity.
Topics: Adhesiveness; Animals; Anti-Bacterial Agents; Chitosan; Clarithromycin; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Eye; Nanoparticles; Particle Size | 2020 |